摘要
炎症在多种血管床的动脉粥样硬化过程中发挥着关键作用,从内皮功能紊乱开始和包含血小板整个的发展阶段。炎症在动脉粥样硬化的起始和发展中的重大贡献已被记录了许多年,但其对与其他心血管疾病发展的贡献仍不清楚。炎症过程构成主动脉疾病(包括主动脉瓣狭窄和主动脉瘤)致病性的一个基本部分。因此,这两个实体均与高发病率和死亡率有关。因此,检测和调查并能够反映疾病进程的且以测量的炎症指数的需求是非常强烈的。然而,这种主动脉疾病的生物标记物,能够对高危病人的早期诊断提供一个重要的存活预后值,但这样的标志物仍然很少。因此,这种生物标记作用的阐明,将有助于对负责主动脉疾病发生的分子和/或细胞水平机制的了解。这一方法能够为早期诊断提供一个病理生理基础。
关键词: 主动脉瘤,主动脉疾病,主动脉夹层,主动脉瓣狭窄,生物标志物。
Current Medicinal Chemistry
Title:Novel Inflammatory Indices in Aortic Disease
Volume: 22 Issue: 23
Author(s): Manolis Vavuranakis, Maria Kariori, Dimitrios Vrachatis, Gerasimos Siasos, Konstantinos Kalogeras, Evelina Bei, Carmen Moldovan, , Maria Lavda, Konstantinos Aznaouridis, Evangelos Oikonomou and Dimitris Tousoulis
Affiliation:
关键词: 主动脉瘤,主动脉疾病,主动脉夹层,主动脉瓣狭窄,生物标志物。
摘要: Inflammation plays a critical role in the atherosclerotic process in various vascular beds, starting from endothelial dysfunction and counting all stages of plaque development. The significant contribution of inflammation in the initiation and progression of atherosclerosis has been documented over many years but its contribution to the development of other cardiovascular disease remains unclear. Inflammatory process constitutes a basic part of pathogenic cascade of aortic diseases including those of aortic valve stenosis and aortic aneurysms. Thus, both of these entities are related with high rates of morbidity and mortality. Therefore, the need to detect and investigate indices representative of inflammation that will be easily measured and may reflect the process of these diseases, is mandatory. However, such biomarkers for aortic diseases that could have a significant prognostic value on survival via the early identification of high risk patients, in general, remain few. Therefore, the illumination of role of such biomarkers, will facilitate the understanding of the mechanisms in molecular and/or cellular level that are responsible for the creation of aortic disease. Such an approach may provide a pathophysiological basis for early diagnosis.
Export Options
About this article
Cite this article as:
Manolis Vavuranakis , Maria Kariori , Dimitrios Vrachatis , Gerasimos Siasos , Konstantinos Kalogeras , Evelina Bei , Carmen Moldovan , , Maria Lavda , Konstantinos Aznaouridis , Evangelos Oikonomou and Dimitris Tousoulis , Novel Inflammatory Indices in Aortic Disease, Current Medicinal Chemistry 2015; 22 (23) . https://dx.doi.org/10.2174/0929867322666150630141035
DOI https://dx.doi.org/10.2174/0929867322666150630141035 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Immunomodulatory Properties of Thalidomide Analogs: Pomalidomide and Lenalidomide, Experimental and Therapeutic Applications
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Conduction Disorders: The Value of Surface ECG
Current Cardiology Reviews Blood Pressure Management in Metabolic Syndrome
Current Hypertension Reviews Inhibitors of Nitric Oxide Synthase: What's up and What's Next?
Current Enzyme Inhibition Uterine Wound Healing: A Complex Process Mediated by Proteins and Peptides
Current Protein & Peptide Science Anti-Inflammatory Drugs and Statins for Arterial Stiffness Reduction
Current Pharmaceutical Design 18F-fluoro-deoxy-D-glucose PET/CT in Establishing the Relationship Between the Metabolic Activity of Aorta and Iliac Artery Aneurysms in Cancer Patients
Current Medical Imaging Atorvastatin Inhibits Advanced Glycation End Products (AGE)-Induced C-Reactive Expression in Hepatoma Cells by Suppressing Reactive Oxygen Species Generation
Vascular Disease Prevention (Discontinued) Matrix Metalloproteinases: A Potential Therapeutic Target in Atherosclerosis
Current Drug Targets - Cardiovascular & Hematological Disorders Perspectives on New Synthetic Curcumin Analogs and their Potential Anticancer Properties
Current Pharmaceutical Design The Wnt/β-catenin Signalling Pathway Inhibitor Sclerostin is a Biomarker for Early Atherosclerosis in Obesity
Current Neurovascular Research Acute Fulminant Hepatatis in Kidney Transplant Recipient After Repeated Sevoflurane Anesthesia - A Case Report and Literature Review
Current Drug Safety Use of N-acetyl-cysteine to Prevent Nephrotoxicity Associated with Iodinated Contrast Agents
Current Drug Therapy Recent Advances in Bioreactors in Tissue Engineering and Regenerative Medicine
Current Tissue Engineering (Discontinued) Effects of Altered Plasminogen Activator Inhibitor-1 Expression on Cardiovascular Disease
Current Drug Targets Nitric Oxide in Cardiac Transplantation
Vascular Disease Prevention (Discontinued) Skeletal Muscle Derived Stem Cells for Myocardial Repair
Recent Patents on Cardiovascular Drug Discovery Nebivolol: More Than a Highly Selective Beta Blocker
Recent Patents on Cardiovascular Drug Discovery Immunomodulatory Effects of Soybeans and Processed Soy Food Compounds
Recent Patents on Food, Nutrition & Agriculture Polymorphism in Endothelin-1 Gene: An Overview
Current Clinical Pharmacology